<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04281069</url>
  </required_header>
  <id_info>
    <org_study_id>OZ7880VLIR-S</org_study_id>
    <nct_id>NCT04281069</nct_id>
  </id_info>
  <brief_title>Diabetes Type 2 in the Eastern Region of Morocco</brief_title>
  <official_title>Diabetes Type 2 in the Eastern Region of Morocco , Towards an Evidence-based Multidisciplinary Lifestyle Approach in Diabetes Type 2</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universiteit Antwerpen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Artesis Plantijn University College, Antwerp</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Université Mohammed Premier, Oujda</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Vliruos</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universiteit Antwerpen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This South Initiative is the first step towards a long-term general objective that aims to
      improve the manage-ment of type 2 diabetes (T2D) and concurrently create jobs for health
      professionals in Eastern Morocco by developing a multidisciplinary approach in the management
      of T2D, based upon international guidelines but adapted to the regional socio-economic and
      cultural context, and with a focus on empowerment of Muslim women.

      The intermediate results of this SI project proposal are: 1) Facilitators and perceived
      barriers in female patients with T2D towards change to a healthier lifestyle are known. 2)
      Characteristics of patients with T2D in the region of Oujda (prevalence, lifestyle, age,
      gender,…) are analysed. 3) Master and bachelor students have gained experience by
      participating to relevant research. 4) All involved stakeholders shared existing and newly
      ac-quired knowledge and expertise. 5) Facilitators and perceived barriers in health
      professionals of different disciplines to work together in the management of T2D are known.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The ultimate objective is to help improve the quality of life and well-being of people living
      with diabetes in the Oujda region.

      This 2-year project will tackle the prerequisites and optimise the conditions needed to start
      a larger (TEAM) project. Afterwards, in the larger long-term (TEAM) project we will study the
      cost-of illness of T2D in Oujda, the effect of a cultural-sensitive multidisciplinary
      intervention for T2D and the cost-effectiveness of such an intervention. In doing so we hope
      to provide not only arguments from a health perspective for such an approach, but also from a
      quality of life and economic point of view. This is needed to persuade political decision
      makers to invest in sustainable innovation in health care. This could open the job market for
      many young physiotherapists, nutritionists and occupational therapists in health centres and
      primary care.

      The specific objectives of this 2-year SI project are 1) to know the characteristics of T2D
      patients in Oujda and their perceived barriers and benefits towards participation in a
      lifestyle program and 2) to improve communication and cooperation between health
      professionals of different disciplines treating patients with T2D.

      The intermediate results of this 2-year project are well defined and feasible (Annex 4). The
      two years of the SI project will be devoted to gathering information from diabetic women as
      well as from health profes-sionals, to creating a platform and to strengthening research
      capacities. The changes needed to reach the SI project outputs are related to 1)
      knowledge/capacity and 2) attitude/behaviour.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>glycaemia</measure>
    <time_frame>first year</time_frame>
    <description>the concentration of glucose in the blood</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hemoglobin A1c</measure>
    <time_frame>first year</time_frame>
    <description>The concentration of hemoglobin A1c in the blood shows the average level of blood sugar over the past 2 to 3 months.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>systolic and diastolic blood pressure</measure>
    <time_frame>first year</time_frame>
    <description>common systolic and diastolic assessment of blood pressure</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">900</enrollment>
  <condition>Quality of Life</condition>
  <condition>Diabetes Mellitus, Type 2</condition>
  <condition>Adherence, Medication</condition>
  <condition>Diet Habit</condition>
  <arm_group>
    <arm_group_label>patients visiting the &quot;centre de santé&quot;</arm_group_label>
    <description>Women visiting to the selected health centres in the Oujda province will be invited to participate</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        step 1) all women, diagnosed with diabetes or not step 2) adults diagnosed with diabetes
        type 2
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  women

          -  visiting the 35 local health centres and the CRD in Oujda

          -  adult

          -  Moroccan

        Exclusion Criteria:

          -  male

          -  no informed consent
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Dirk Vissers, PhD</last_name>
    <phone>+3232652648</phone>
    <email>dirk.vissers@uantwerpen.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Dimitri Geelhand de Merxem, Ms</last_name>
    <phone>+3232652648</phone>
    <email>Dimitri.GeelhanddeMerxem@uantwerpen.be</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Université Mohammed Premier Oujda (UMP) Faculté des Sciences, Département de Biologie</name>
      <address>
        <city>Oujda</city>
        <state>Oujda Angad</state>
        <zip>60000</zip>
        <country>Morocco</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Abdellatif Maamri, Prof dr</last_name>
      <phone>00212 536689837</phone>
      <email>abdellatifm@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Dirk Vissers, dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bart Van Rompaey, dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Abderrahim Ziyat, Prof dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Morocco</country>
  </location_countries>
  <link>
    <url>http://www.uantwerpen.be/nl/personeel/dirk-vissers/vlir-uos-south-initi/</url>
    <description>project page</description>
  </link>
  <reference>
    <citation>Pollard TM, Guell C. Assessing physical activity in Muslim women of South Asian origin. J Phys Act Health. 2012 Sep;9(7):970-6.</citation>
    <PMID>22971888</PMID>
  </reference>
  <reference>
    <citation>Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004 May;27(5):1047-53.</citation>
    <PMID>15111519</PMID>
  </reference>
  <reference>
    <citation>Abuyassin B, Laher I. Diabetes epidemic sweeping the Arab world. World J Diabetes. 2016 Apr 25;7(8):165-74. doi: 10.4239/wjd.v7.i8.165. Review.</citation>
    <PMID>27114755</PMID>
  </reference>
  <reference>
    <citation>Palmer AJ, Roze S, Valentine WJ, Spinas GA, Shaw JE, Zimmet PZ. Intensive lifestyle changes or metformin in patients with impaired glucose tolerance: modeling the long-term health economic implications of the diabetes prevention program in Australia, France, Germany, Switzerland, and the United Kingdom. Clin Ther. 2004 Feb;26(2):304-21.</citation>
    <PMID>15038953</PMID>
  </reference>
  <reference>
    <citation>Lindström J, Peltonen M, Eriksson JG, Ilanne-Parikka P, Aunola S, Keinänen-Kiukaanniemi S, Uusitupa M, Tuomilehto J; Finnish Diabetes Prevention Study (DPS). Improved lifestyle and decreased diabetes risk over 13 years: long-term follow-up of the randomised Finnish Diabetes Prevention Study (DPS). Diabetologia. 2013 Feb;56(2):284-93. doi: 10.1007/s00125-012-2752-5. Epub 2012 Oct 24.</citation>
    <PMID>23093136</PMID>
  </reference>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 15, 2019</study_first_submitted>
  <study_first_submitted_qc>February 20, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 24, 2020</study_first_posted>
  <last_update_submitted>February 25, 2020</last_update_submitted>
  <last_update_submitted_qc>February 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universiteit Antwerpen</investigator_affiliation>
    <investigator_full_name>Van Rompaey Bart</investigator_full_name>
    <investigator_title>associated professor</investigator_title>
  </responsible_party>
  <keyword>diabetes mellitus type 2</keyword>
  <keyword>quality of life</keyword>
  <keyword>interdisciplinary care</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

